Hanmi Science Cash Flow Conversion Efficiency
Hanmi Science cash flow conversion efficiency. Based on the latest financial reports, Hanmi Science (008930) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.96 Billion ≈ $5.39 Million USD) by net assets (₩1.00 Trillion ≈ $677.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hanmi Science (2000–2025)
Cash flow conversion efficiency of Hanmi Science from 2000 to 2025. This chart illustrates how Hanmi Science's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hanmi Science stock quote for real-time trading data and today's change.
Hanmi Science Cash Flow Conversion Ratio Explained
Hanmi Science cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hanmi Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hanmi Science ranked by their cash flow conversion efficiency. Also see Hanmi Science (008930) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anywhere Real Estate Inc
NYSE:HOUS
|
0.078x |
|
Anhui Jingcheng Copper Share Co Ltd
SHE:002171
|
-0.009x |
|
IBF Financial Holdings Co Ltd
TW:2889
|
-0.017x |
|
Alliance Financial Group Bhd
KLSE:2488
|
0.000x |
|
Sh Belling
SHG:600171
|
0.055x |
|
XiAn Shaangu Power Co Ltd
SHG:601369
|
0.035x |
|
Central China Land Media Co Ltd
SHE:000719
|
-0.033x |
|
Jiangsu Shemar Electric Co Ltd
SHG:603530
|
0.044x |
Annual Cash Flow Conversion Efficiency for Hanmi Science (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hanmi Science from 2000 to 2025. Review Hanmi Science free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩959.19 Billion ≈ $650.03 Million |
₩47.66 Billion ≈ $32.30 Million |
0.050x | -49.79% |
| 2024-12-31 | ₩838.70 Billion ≈ $568.38 Million |
₩82.99 Billion ≈ $56.24 Million |
0.099x | +121.62% |
| 2023-12-31 | ₩787.47 Billion ≈ $533.66 Million |
₩35.16 Billion ≈ $23.83 Million |
0.045x | +242.35% |
| 2022-12-31 | ₩724.75 Billion ≈ $491.15 Million |
₩9.45 Billion ≈ $6.41 Million |
0.013x | -34.24% |
| 2021-12-31 | ₩690.29 Billion ≈ $467.80 Million |
₩13.69 Billion ≈ $9.28 Million |
0.020x | -5.45% |
| 2020-12-31 | ₩658.73 Billion ≈ $446.41 Million |
₩13.82 Billion ≈ $9.36 Million |
0.021x | +3.99% |
| 2019-12-31 | ₩645.69 Billion ≈ $437.57 Million |
₩13.02 Billion ≈ $8.83 Million |
0.020x | +387.66% |
| 2018-12-31 | ₩653.09 Billion ≈ $442.59 Million |
₩2.70 Billion ≈ $1.83 Million |
0.004x | +108.17% |
| 2017-12-31 | ₩665.15 Billion ≈ $450.76 Million |
₩-33.68 Billion ≈ $-22.83 Million |
-0.051x | -142.85% |
| 2016-12-31 | ₩647.56 Billion ≈ $438.84 Million |
₩76.52 Billion ≈ $51.86 Million |
0.118x | +47.12% |
| 2015-12-31 | ₩584.25 Billion ≈ $395.94 Million |
₩46.93 Billion ≈ $31.80 Million |
0.080x | +539.61% |
| 2014-12-31 | ₩417.71 Billion ≈ $283.08 Million |
₩5.25 Billion ≈ $3.55 Million |
0.013x | +2287.90% |
| 2013-12-31 | ₩409.07 Billion ≈ $277.22 Million |
₩-234.79 Million ≈ $-159.11K |
-0.001x | -100.95% |
| 2010-12-31 | ₩604.83 Billion ≈ $409.88 Million |
₩36.49 Billion ≈ $24.73 Million |
0.060x | -55.95% |
| 2009-12-31 | ₩444.88 Billion ≈ $301.49 Million |
₩60.93 Billion ≈ $41.29 Million |
0.137x | +31.54% |
| 2008-12-31 | ₩393.00 Billion ≈ $266.33 Million |
₩40.92 Billion ≈ $27.73 Million |
0.104x | -48.66% |
| 2006-12-31 | ₩291.16 Billion ≈ $197.32 Million |
₩59.05 Billion ≈ $40.02 Million |
0.203x | -4.83% |
| 2005-12-31 | ₩219.66 Billion ≈ $148.86 Million |
₩46.81 Billion ≈ $31.72 Million |
0.213x | +53.31% |
| 2004-12-31 | ₩181.81 Billion ≈ $123.21 Million |
₩25.27 Billion ≈ $17.13 Million |
0.139x | -4.75% |
| 2003-12-31 | ₩155.62 Billion ≈ $105.46 Million |
₩22.71 Billion ≈ $15.39 Million |
0.146x | -34.08% |
| 2002-12-31 | ₩146.43 Billion ≈ $99.23 Million |
₩32.42 Billion ≈ $21.97 Million |
0.221x | -22.75% |
| 2001-12-31 | ₩131.69 Billion ≈ $89.25 Million |
₩37.74 Billion ≈ $25.58 Million |
0.287x | +39.40% |
| 2000-12-31 | ₩90.93 Billion ≈ $61.62 Million |
₩18.69 Billion ≈ $12.67 Million |
0.206x | -- |
About Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more